Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Chemical & Material > Global and United States Recombinant Collagen-Based Biomaterial Market Report & Forecast 2024-2030

Global and United States Recombinant Collagen-Based Biomaterial Market Report & Forecast 2024-2030

Global and United States Recombinant Collagen-Based Biomaterial Market Report & Forecast 2024-2030

Industry: Chemical & Material

Published: 2024-06-07

Pages: 120 Pages

Report ld: 3191310

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.

The global Recombinant Collagen-Based Biomaterial revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
In United States the Recombinant Collagen-Based Biomaterial revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States Recombinant Collagen-Based Biomaterial market, also covers the segmentation data of other regions in regional level and county level.

Recombinant collagen-based biomaterials are produced through biotechnology, with advantages such as high purity, good quality consistency, and no animal pathogens, which greatly reduces the risk of immune response. This material shows broad application prospects in the fields of medicine, pharmaceuticals, cosmetics, food, and bioprinting. In medicine, recombinant collagen is used in tissue engineering and wound repair to promote tissue regeneration and healing; in the cosmetic field, it has become an important ingredient in skin care products due to its excellent moisturizing and anti-aging properties; in food and nutritional supplements, recombinant collagen provides health and beauty benefits and supports joint and skin health. In addition, recombinant collagen is used in 3D bioprinting technology to help build complex biological structures and develop tissue engineering. The versatility and safety of this material make it a key factor in promoting innovation and development in multiple industries.

Recombinant Collagen-Based Biomaterial market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Recombinant Collagen-Based Biomaterial market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the Recombinant Collagen-Based Biomaterial market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Global and United States Recombinant Collagen-Based Biomaterial Market Report & Forecast 2024-2030

  • Market Size Available for Years

  • 2024-2030

  • Global Recombinant Collagen-Based Biomaterial Companies Covered

  • Evonik Industries

    Trautec

    Genemedicine

    FibroGen

    CollPlant

    Geltor

    Modern Meadow

  • Global Recombinant Collagen-Based Biomaterial Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Recombinant Collagen-Based Biomaterial Market, Segment by Type

  • Medical Grade Recombinant Collagen

    Cosmetic Grade Recombinant Collagen

    Food Grade Recombinant Collagen

    Others

  • Global Recombinant Collagen-Based Biomaterial Market, Segment by Application

  • Medical Industry

    Cosmetic Industry

    Food Industry

    Others

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces Recombinant Collagen-Based Biomaterial definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Recombinant Collagen-Based Biomaterial companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Recombinant Collagen-Based Biomaterial in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world. 
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Collagen-Based Biomaterial sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion

Table of Contents

1 Study Coverage
    1.1 Recombinant Collagen-Based Biomaterial Product Introduction
    1.2 Global Recombinant Collagen-Based Biomaterial Outlook 2019 VS 2023 VS 2030
        1.2.1 Global Recombinant Collagen-Based Biomaterial Sales in US$ Million for the Year 2019-2030
        1.2.2 Global Recombinant Collagen-Based Biomaterial Sales in Volume for the Year 2019-2030
    1.3 United States Recombinant Collagen-Based Biomaterial Outlook 2019 VS 2023 VS 2030
        1.3.1 United States Recombinant Collagen-Based Biomaterial Sales in US$ Million for the Year 2019-2030
        1.3.2 United States Recombinant Collagen-Based Biomaterial Sales in Volume for the Year 2019-2030
    1.4 Recombinant Collagen-Based Biomaterial Market Size, United States VS Global, 2019 VS 2023 VS 2030
        1.4.1 The Market Share of United States Recombinant Collagen-Based Biomaterial in Global, 2019 VS 2023 VS 2030
        1.4.2 The Growth Rate of Recombinant Collagen-Based Biomaterial Market Size, United States VS Global, 2019 VS 2023 VS 2030
    1.5 Recombinant Collagen-Based Biomaterial Market Dynamics
        1.5.1 Recombinant Collagen-Based Biomaterial Industry Trends
        1.5.2 Recombinant Collagen-Based Biomaterial Market Drivers
        1.5.3 Recombinant Collagen-Based Biomaterial Market Challenges
        1.5.4 Recombinant Collagen-Based Biomaterial Market Restraints
    1.6 Assumptions and Limitations
    1.7 Study Objectives
    1.8 Years Considered
2 Recombinant Collagen-Based Biomaterial by Type
    2.1 Recombinant Collagen-Based Biomaterial Market by Type
        2.1.1 Medical Grade Recombinant Collagen
        2.1.2 Cosmetic Grade Recombinant Collagen
        2.1.3 Food Grade Recombinant Collagen
        2.1.4 Others
    2.2 Global Recombinant Collagen-Based Biomaterial Market Size by Type
        2.2.1 Global Recombinant Collagen-Based Biomaterial Sales in Value, by Type (2019, 2023 & 2030)
        2.2.2 Global Recombinant Collagen-Based Biomaterial Sales in Volume, by Type (2019, 2023 & 2030)
        2.2.3 Global Recombinant Collagen-Based Biomaterial Average Selling Price (ASP) by Type (2019, 2023 & 2030)
    2.3 United States Recombinant Collagen-Based Biomaterial Market Size by Type
        2.3.1 United States Recombinant Collagen-Based Biomaterial Sales in Value, by Type (2019, 2023 & 2030)
        2.3.2 United States Recombinant Collagen-Based Biomaterial Sales in Volume, by Type (2019, 2023 & 2030)
        2.3.3 United States Recombinant Collagen-Based Biomaterial Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3 Recombinant Collagen-Based Biomaterial by Application
    3.1 Recombinant Collagen-Based Biomaterial Market by Application
        3.1.1 Medical Industry
        3.1.2 Cosmetic Industry
        3.1.3 Food Industry
        3.1.4 Others
    3.2 Global Recombinant Collagen-Based Biomaterial Market Size by Application
        3.2.1 Global Recombinant Collagen-Based Biomaterial Sales in Value, by Application (2019, 2023 & 2030)
        3.2.2 Global Recombinant Collagen-Based Biomaterial Sales in Volume, by Application (2019, 2023 & 2030)
        3.2.3 Global Recombinant Collagen-Based Biomaterial Average Selling Price (ASP) by Application (2019, 2023 & 2030)
    3.3 United States Recombinant Collagen-Based Biomaterial Market Size by Application
        3.3.1 United States Recombinant Collagen-Based Biomaterial Sales in Value, by Application (2019, 2023 & 2030)
        3.3.2 United States Recombinant Collagen-Based Biomaterial Sales in Volume, by Application (2019, 2023 & 2030)
        3.3.3 United States Recombinant Collagen-Based Biomaterial Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4 Global Recombinant Collagen-Based Biomaterial Competitor Landscape by Company
    4.1 Global Recombinant Collagen-Based Biomaterial Market Size by Company
        4.1.1 Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Ranked by Revenue (2023)
        4.1.2 Global Recombinant Collagen-Based Biomaterial Revenue by Manufacturer (2019-2024)
        4.1.3 Global Recombinant Collagen-Based Biomaterial Sales by Manufacturer (2019-2024)
        4.1.4 Global Recombinant Collagen-Based Biomaterial Price by Manufacturer (2019-2024)
    4.2 Global Recombinant Collagen-Based Biomaterial Concentration Ratio (CR)
        4.2.1 Recombinant Collagen-Based Biomaterial Market Concentration Ratio (CR) (2019-2024)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Recombinant Collagen-Based Biomaterial in 2023
        4.2.3 Global Recombinant Collagen-Based Biomaterial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Manufacturing Base Distribution and Headquarters
    4.4 Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Product Offered and Application
    4.5 Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Date of Enter into This Industry
    4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.7 United States Recombinant Collagen-Based Biomaterial Market Size by Company
        4.7.1 Key Players of Recombinant Collagen-Based Biomaterial in United States, Ranked by Revenue (2023)
        4.7.2 United States Recombinant Collagen-Based Biomaterial Revenue by Players (2019-2024)
        4.7.3 United States Recombinant Collagen-Based Biomaterial Sales by Players (2019-2024)
5 Global Recombinant Collagen-Based Biomaterial Market Size by Region
    5.1 Global Recombinant Collagen-Based Biomaterial Market Size by Region: 2019 VS 2023 VS 2030
    5.2 Global Recombinant Collagen-Based Biomaterial Market Size in Volume by Region (2019-2030)
        5.2.1 Global Recombinant Collagen-Based Biomaterial Sales in Volume by Region: 2019-2024
        5.2.2 Global Recombinant Collagen-Based Biomaterial Sales in Volume Forecast by Region (2025-2030)
    5.3 Global Recombinant Collagen-Based Biomaterial Market Size in Value by Region (2019-2030)
        5.3.1 Global Recombinant Collagen-Based Biomaterial Sales in Value by Region: 2019-2024
        5.3.2 Global Recombinant Collagen-Based Biomaterial Sales in Value by Region: 2025-2030
6 Americas
    6.1 Americas Recombinant Collagen-Based Biomaterial Market Size YoY Growth 2019-2030
    6.2 Americas Recombinant Collagen-Based Biomaterial Sales in Volume, by Type (2019, 2023 & 2030)
    6.3 Americas Recombinant Collagen-Based Biomaterial Sales in Volume, by Application (2019, 2023 & 2030)
    6.4 Americas Recombinant Collagen-Based Biomaterial Market Facts & Figures by Country (2019, 2023 & 2030)
        6.4.1 Americas Recombinant Collagen-Based Biomaterial Sales in Value by Country (2019, 2023 & 2030)
        6.4.2 Americas Recombinant Collagen-Based Biomaterial Sales in Volume by Country (2019, 2023 & 2030)
        6.4.3 United States
        6.4.4 Canada
        6.4.5 Mexico
        6.4.6 Brazil
7 EMEA
    7.1 EMEA Recombinant Collagen-Based Biomaterial Market Size YoY Growth 2019-2030
    7.2 EMEA Recombinant Collagen-Based Biomaterial Sales in Volume, by Type (2019, 2023 & 2030)
    7.3 EMEA Recombinant Collagen-Based Biomaterial Sales in Volume, by Application (2019, 2023 & 2030)
    7.4 EMEA Recombinant Collagen-Based Biomaterial Market Facts & Figures by Country (2019, 2023 & 2030)
        7.4.1 EMEA Recombinant Collagen-Based Biomaterial Sales in Value by Country (2019, 2023 & 2030)
        7.4.2 EMEA Recombinant Collagen-Based Biomaterial Sales in Volume by Country (2019, 2023 & 2030)
        7.4.3 Europe
        7.4.4 Middle East
        7.4.5 Africa
8 China
    8.1 China Recombinant Collagen-Based Biomaterial Market Size YoY Growth 2019-2030
    8.2 China Recombinant Collagen-Based Biomaterial Sales in Volume, by Type (2019, 2023 & 2030)
    8.3 China Recombinant Collagen-Based Biomaterial Sales in Volume, by Application (2019, 2023 & 2030)
9 APAC
    9.1 APAC Recombinant Collagen-Based Biomaterial Market Size YoY Growth 2019-2030
    9.2 APAC Recombinant Collagen-Based Biomaterial Sales in Volume, by Type (2019, 2023 & 2030)
    9.3 APAC Recombinant Collagen-Based Biomaterial Sales in Volume, by Application (2019, 2023 & 2030)
    9.4 APAC Recombinant Collagen-Based Biomaterial Market Facts & Figures by Country (2019, 2023 & 2030)
        9.4.1 APAC Recombinant Collagen-Based Biomaterial Sales in Value by Country (2019, 2023 & 2030)
        9.4.2 APAC Recombinant Collagen-Based Biomaterial Sales in Volume by Country (2019, 2023 & 2030)
        9.4.3 Japan
        9.4.4 South Korea
        9.4.5 China Taiwan
        9.4.6 Southeast Asia
        9.4.7 India
10 Company Profiles
    10.1 Evonik Industries
        10.1.1 Evonik Industries Company Information
        10.1.2 Evonik Industries Description and Business Overview
        10.1.3 Evonik Industries Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2019-2024)
        10.1.4 Evonik Industries Recombinant Collagen-Based Biomaterial Products Offered
        10.1.5 Evonik Industries Recent Development
    10.2 Trautec
        10.2.1 Trautec Company Information
        10.2.2 Trautec Description and Business Overview
        10.2.3 Trautec Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2019-2024)
        10.2.4 Trautec Recombinant Collagen-Based Biomaterial Products Offered
        10.2.5 Trautec Recent Development
    10.3 Genemedicine
        10.3.1 Genemedicine Company Information
        10.3.2 Genemedicine Description and Business Overview
        10.3.3 Genemedicine Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2019-2024)
        10.3.4 Genemedicine Recombinant Collagen-Based Biomaterial Products Offered
        10.3.5 Genemedicine Recent Development
    10.4 FibroGen
        10.4.1 FibroGen Company Information
        10.4.2 FibroGen Description and Business Overview
        10.4.3 FibroGen Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2019-2024)
        10.4.4 FibroGen Recombinant Collagen-Based Biomaterial Products Offered
        10.4.5 FibroGen Recent Development
    10.5 CollPlant
        10.5.1 CollPlant Company Information
        10.5.2 CollPlant Description and Business Overview
        10.5.3 CollPlant Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2019-2024)
        10.5.4 CollPlant Recombinant Collagen-Based Biomaterial Products Offered
        10.5.5 CollPlant Recent Development
    10.6 Geltor
        10.6.1 Geltor Company Information
        10.6.2 Geltor Description and Business Overview
        10.6.3 Geltor Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2019-2024)
        10.6.4 Geltor Recombinant Collagen-Based Biomaterial Products Offered
        10.6.5 Geltor Recent Development
    10.7 Modern Meadow
        10.7.1 Modern Meadow Company Information
        10.7.2 Modern Meadow Description and Business Overview
        10.7.3 Modern Meadow Recombinant Collagen-Based Biomaterial Sales, Revenue and Gross Margin (2019-2024)
        10.7.4 Modern Meadow Recombinant Collagen-Based Biomaterial Products Offered
        10.7.5 Modern Meadow Recent Development
11 Industry Chain and Sales Channels Analysis
    11.1 Recombinant Collagen-Based Biomaterial Industry Chain Analysis
    11.2 Recombinant Collagen-Based Biomaterial Key Raw Materials
        11.2.1 Key Raw Materials
        11.2.2 Raw Materials Key Suppliers
    11.3 Recombinant Collagen-Based Biomaterial Production Mode & Process
    11.4 Recombinant Collagen-Based Biomaterial Sales and Marketing
        11.4.1 Recombinant Collagen-Based Biomaterial Sales Channels
        11.4.2 Recombinant Collagen-Based Biomaterial Distributors
    11.5 Recombinant Collagen-Based Biomaterial Customers
12 Research Findings and Conclusion
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Recombinant Collagen-Based Biomaterial CAGR in Value, United States VS Global, 2019 VS 2023 VS 2030
 Table 2. Recombinant Collagen-Based Biomaterial Market Trends
 Table 3. Recombinant Collagen-Based Biomaterial Market Drivers
 Table 4. Recombinant Collagen-Based Biomaterial Market Challenges
 Table 5. Recombinant Collagen-Based Biomaterial Market Restraints
 Table 6. Global Recombinant Collagen-Based Biomaterial Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 7. United States Recombinant Collagen-Based Biomaterial Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 8. Global Recombinant Collagen-Based Biomaterial Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 9. United States Recombinant Collagen-Based Biomaterial Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 10. Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Ranked by Revenue (2023) & (US$ Million)
 Table 11. Global Recombinant Collagen-Based Biomaterial Revenue by Manufacturer, (US$ Million) & (2019-2024)
 Table 12. Global Recombinant Collagen-Based Biomaterial Revenue Share by Manufacturer, 2019-2024
 Table 13. Global Recombinant Collagen-Based Biomaterial Sales by Manufacturer, (Tons), 2019-2024
 Table 14. Global Recombinant Collagen-Based Biomaterial Sales Share by Manufacturer, 2019-2024
 Table 15. Global Recombinant Collagen-Based Biomaterial Price by Manufacturer (2019-2024) & (US$/Ton)
 Table 16. Global Recombinant Collagen-Based Biomaterial Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 17. Global Recombinant Collagen-Based Biomaterial by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Collagen-Based Biomaterial as of 2023)
 Table 18. Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Manufacturing Base Distribution and Headquarters
 Table 19. Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Product Offered and Application
 Table 20. Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Date of Enter into This Industry
 Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 22. Key Players of Recombinant Collagen-Based Biomaterial in United States, Ranked by Revenue (2023) & (US$ million)
 Table 23. United States Recombinant Collagen-Based Biomaterial Revenue by Players, (US$ Million) & (2019-2024)
 Table 24. United States Recombinant Collagen-Based Biomaterial Revenue Share by Players, (2019-2024)
 Table 25. United States Recombinant Collagen-Based Biomaterial Sales by Players, (Tons) & (2019-2024)
 Table 26. United States Recombinant Collagen-Based Biomaterial Sales Share by Players, (2019-2024)
 Table 27. Global Recombinant Collagen-Based Biomaterial Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 28. Global Recombinant Collagen-Based Biomaterial Sales in Volume by Region (2019-2024) & (Tons)
 Table 29. Global Recombinant Collagen-Based Biomaterial Sales in Volume Forecast by Region (2025-2030) & (Tons)
 Table 30. Global Recombinant Collagen-Based Biomaterial Sales in Value by Region (2019-2024) & (US$ Million)
 Table 31. Global Recombinant Collagen-Based Biomaterial Sales in Value Forecast by Region (2025-2030) & (US$ Million)
 Table 32. Americas Recombinant Collagen-Based Biomaterial Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. Americas Recombinant Collagen-Based Biomaterial Sales in Value by Country (2019-2024) & (US$ Million)
 Table 34. Americas Recombinant Collagen-Based Biomaterial Sales in Value by Country (2025-2030) & (US$ Million)
 Table 35. Americas Recombinant Collagen-Based Biomaterial Sales in Volume by Country (2019-2024) & (Tons)
 Table 36. Americas Recombinant Collagen-Based Biomaterial Sales in Volume by Country (2025-2030) & (Tons)
 Table 37. EMEA Recombinant Collagen-Based Biomaterial Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. EMEA Recombinant Collagen-Based Biomaterial Sales in Value by Country (2019-2024) & (US$ Million)
 Table 39. EMEA Recombinant Collagen-Based Biomaterial Sales in Value by Country (2025-2030) & (US$ Million)
 Table 40. EMEA Recombinant Collagen-Based Biomaterial Sales in Volume by Country (2019-2024) & (Tons)
 Table 41. EMEA Recombinant Collagen-Based Biomaterial Sales in Volume by Country (2025-2030) & (Tons)
 Table 42. APAC Recombinant Collagen-Based Biomaterial Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. APAC Recombinant Collagen-Based Biomaterial Sales in Value by Country (2019-2024) & (US$ Million)
 Table 44. APAC Recombinant Collagen-Based Biomaterial Sales in Value by Country (2025-2030) & (US$ Million)
 Table 45. APAC Recombinant Collagen-Based Biomaterial Sales in Volume by Country (2019-2024) & (Tons)
 Table 46. APAC Recombinant Collagen-Based Biomaterial Sales in Volume by Country (2025-2030) & (Tons)
 Table 47. Evonik Industries Company Information
 Table 48. Evonik Industries Description and Business Overview
 Table 49. Evonik Industries Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 50. Evonik Industries Recombinant Collagen-Based Biomaterial Product
 Table 51. Evonik Industries Recent Development
 Table 52. Trautec Company Information
 Table 53. Trautec Description and Business Overview
 Table 54. Trautec Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 55. Trautec Recombinant Collagen-Based Biomaterial Product
 Table 56. Trautec Recent Development
 Table 57. Genemedicine Company Information
 Table 58. Genemedicine Description and Business Overview
 Table 59. Genemedicine Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 60. Genemedicine Recombinant Collagen-Based Biomaterial Product
 Table 61. Genemedicine Recent Development
 Table 62. FibroGen Company Information
 Table 63. FibroGen Description and Business Overview
 Table 64. FibroGen Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 65. FibroGen Recombinant Collagen-Based Biomaterial Product
 Table 66. FibroGen Recent Development
 Table 67. CollPlant Company Information
 Table 68. CollPlant Description and Business Overview
 Table 69. CollPlant Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 70. CollPlant Recombinant Collagen-Based Biomaterial Product
 Table 71. CollPlant Recent Development
 Table 72. Geltor Company Information
 Table 73. Geltor Description and Business Overview
 Table 74. Geltor Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 75. Geltor Recombinant Collagen-Based Biomaterial Product
 Table 76. Geltor Recent Development
 Table 77. Modern Meadow Company Information
 Table 78. Modern Meadow Description and Business Overview
 Table 79. Modern Meadow Recombinant Collagen-Based Biomaterial Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 80. Modern Meadow Recombinant Collagen-Based Biomaterial Product
 Table 81. Modern Meadow Recent Development
 Table 82. Key Raw Materials Lists
 Table 83. Raw Materials Key Suppliers Lists
 Table 84. Recombinant Collagen-Based Biomaterial Distributors List
 Table 85. Recombinant Collagen-Based Biomaterial Customers List
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources


List of Figures
 Figure 1. Recombinant Collagen-Based Biomaterial Product Picture
 Figure 2. Global Recombinant Collagen-Based Biomaterial Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 3. Global Recombinant Collagen-Based Biomaterial Market Size 2019-2030 (US$ Million)
 Figure 4. Global Recombinant Collagen-Based Biomaterial Sales 2019-2030 (Tons)
 Figure 5. United States Recombinant Collagen-Based Biomaterial Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 6. United States Recombinant Collagen-Based Biomaterial Market Size 2019-2030 (US$ Million)
 Figure 7. United States Recombinant Collagen-Based Biomaterial Sales 2019-2030 (Tons)
 Figure 8. United States Recombinant Collagen-Based Biomaterial Market Share in Global, in Value (US$ Million) 2019-2030
 Figure 9. United States Recombinant Collagen-Based Biomaterial Market Share in Global, in Volume (Tons) 2019-2030
 Figure 10. Recombinant Collagen-Based Biomaterial Report Years Considered
 Figure 11. Product Picture of Medical Grade Recombinant Collagen
 Figure 12. Product Picture of Cosmetic Grade Recombinant Collagen
 Figure 13. Product Picture of Food Grade Recombinant Collagen
 Figure 14. Product Picture of Others
 Figure 15. Global Recombinant Collagen-Based Biomaterial Market Share by Type in 2023 & 2030
 Figure 16. Global Recombinant Collagen-Based Biomaterial Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 17. Global Recombinant Collagen-Based Biomaterial Sales Market Share in Value by Type (2019-2030)
 Figure 18. Global Recombinant Collagen-Based Biomaterial Sales by Type (2019-2030) & (Tons)
 Figure 19. Global Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Type (2019-2030)
 Figure 20. Global Recombinant Collagen-Based Biomaterial Price by Type (2019-2030) & (US$/Ton)
 Figure 21. United States Recombinant Collagen-Based Biomaterial Market Share by Type in 2023 & 2030
 Figure 22. United States Recombinant Collagen-Based Biomaterial Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 23. United States Recombinant Collagen-Based Biomaterial Sales Market Share in Value by Type (2019-2030)
 Figure 24. United States Recombinant Collagen-Based Biomaterial Sales by Type (2019-2030) & (Tons)
 Figure 25. United States Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Type (2019-2030)
 Figure 26. United States Recombinant Collagen-Based Biomaterial Price by Type (2019-2030) & (US$/Ton)
 Figure 27. Product Picture of Medical Industry
 Figure 28. Product Picture of Cosmetic Industry
 Figure 29. Product Picture of Food Industry
 Figure 30. Product Picture of Others
 Figure 31. Global Recombinant Collagen-Based Biomaterial Market Share by Application in 2023 & 2030
 Figure 32. Global Recombinant Collagen-Based Biomaterial Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 33. Global Recombinant Collagen-Based Biomaterial Sales Market Share in Value by Application (2019-2030)
 Figure 34. Global Recombinant Collagen-Based Biomaterial Sales by Application (2019-2030) & (Tons)
 Figure 35. Global Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Application (2019-2030)
 Figure 36. Global Recombinant Collagen-Based Biomaterial Price by Application (2019-2030) & (US$/Ton)
 Figure 37. United States Recombinant Collagen-Based Biomaterial Market Share by Application in 2023 & 2030
 Figure 38. United States Recombinant Collagen-Based Biomaterial Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 39. United States Recombinant Collagen-Based Biomaterial Sales Market Share in Value by Application (2019-2030)
 Figure 40. United States Recombinant Collagen-Based Biomaterial Sales by Application (2019-2030) & (Tons)
 Figure 41. United States Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Application (2019-2030)
 Figure 42. United States Recombinant Collagen-Based Biomaterial Price by Application (2019-2030) & (US$/Ton)
 Figure 43. The Top 5 and 10 Largest Manufacturers of Recombinant Collagen-Based Biomaterial in the World: Market Share by Recombinant Collagen-Based Biomaterial Revenue in 2023
 Figure 44. Global Recombinant Collagen-Based Biomaterial Market Size Market Share by Region: 2019 VS 2023 VS 2030
 Figure 45. Global Recombinant Collagen-Based Biomaterial Sales in Volume Market Share by Region (2019-2030)
 Figure 46. Global Recombinant Collagen-Based Biomaterial Sales in Value Market Share by Region (2019-2030)
 Figure 47. Americas Recombinant Collagen-Based Biomaterial Sales in Volume Growth Rate 2019-2030 (Tons)
 Figure 48. Americas Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 49. Americas Recombinant Collagen-Based Biomaterial Sales by Type (2019-2030) & (Tons)
 Figure 50. Americas Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Type (2019-2030)
 Figure 51. Americas Recombinant Collagen-Based Biomaterial Sales by Application (2019-2030) & (Tons)
 Figure 52. Americas Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Application (2019-2030)
 Figure 53. United States Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Canada Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 55. Mexico Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 56. Brazil Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 57. EMEA Recombinant Collagen-Based Biomaterial Sales in Volume Growth Rate 2019-2030 (Tons)
 Figure 58. EMEA Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 59. EMEA Recombinant Collagen-Based Biomaterial Sales by Type (2019-2030) & (Tons)
 Figure 60. EMEA Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Type (2019-2030)
 Figure 61. EMEA Recombinant Collagen-Based Biomaterial Sales by Application (2019-2030) & (Tons)
 Figure 62. EMEA Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Application (2019-2030)
 Figure 63. Europe Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 64. Middle East Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 65. Africa Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 66. China Recombinant Collagen-Based Biomaterial Sales in Volume Growth Rate 2019-2030 (Tons)
 Figure 67. China Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 68. China Recombinant Collagen-Based Biomaterial Sales by Type (2019-2030) & (Tons)
 Figure 69. China Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Type (2019-2030)
 Figure 70. China Recombinant Collagen-Based Biomaterial Sales by Application (2019-2030) & (Tons)
 Figure 71. China Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Application (2019-2030)
 Figure 72. APAC Recombinant Collagen-Based Biomaterial Sales in Volume Growth Rate 2019-2030 (Tons)
 Figure 73. APAC Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 74. APAC Recombinant Collagen-Based Biomaterial Sales by Type (2019-2030) & (Tons)
 Figure 75. APAC Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Type (2019-2030)
 Figure 76. APAC Recombinant Collagen-Based Biomaterial Sales by Application (2019-2030) & (Tons)
 Figure 77. APAC Recombinant Collagen-Based Biomaterial Sales Market Share in Volume by Application (2019-2030)
 Figure 78. Japan Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 79. South Korea Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 80. China Taiwan Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 81. Southeast Asia Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 82. India Recombinant Collagen-Based Biomaterial Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 83. Recombinant Collagen-Based Biomaterial Value Chain
 Figure 84. Recombinant Collagen-Based Biomaterial Production Process
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed

Description

Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.

The global Recombinant Collagen-Based Biomaterial revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
In United States the Recombinant Collagen-Based Biomaterial revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States Recombinant Collagen-Based Biomaterial market, also covers the segmentation data of other regions in regional level and county level.

Recombinant collagen-based biomaterials are produced through biotechnology, with advantages such as high purity, good quality consistency, and no animal pathogens, which greatly reduces the risk of immune response. This material shows broad application prospects in the fields of medicine, pharmaceuticals, cosmetics, food, and bioprinting. In medicine, recombinant collagen is used in tissue engineering and wound repair to promote tissue regeneration and healing; in the cosmetic field, it has become an important ingredient in skin care products due to its excellent moisturizing and anti-aging properties; in food and nutritional supplements, recombinant collagen provides health and beauty benefits and supports joint and skin health. In addition, recombinant collagen is used in 3D bioprinting technology to help build complex biological structures and develop tissue engineering. The versatility and safety of this material make it a key factor in promoting innovation and development in multiple industries.

Recombinant Collagen-Based Biomaterial market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Recombinant Collagen-Based Biomaterial market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the Recombinant Collagen-Based Biomaterial market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

Market Segmentation
Chapter Outline
Chapter 1: Introduces Recombinant Collagen-Based Biomaterial definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Recombinant Collagen-Based Biomaterial companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Recombinant Collagen-Based Biomaterial in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world. 
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Collagen-Based Biomaterial sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion

Related Reports

Global and United States Recombinant Collagen-Based Biomaterial Market Report & Forecast 2024-2030

Industry: Chemical & Material

Published: 2024-06-07

Pages: 120 Pages

Report ld: 3191310

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 4350.00

tip

USD 6525.00

tip

USD 8700.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now